Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Microvasculopathy does not predict coronary artery disease of the transplanted heart

M Zakliczyński, J Nożyński, D Konecka-Mrówka, Ł Pyka, D Trybunia, A Lekston, M Świerad, R Przybylski, M Zembala

Ann Transplant 2009; 14(1): 65-66 :: ID: 880439

Abstract

Background: A relation between microvasculopathy observed in endomyocardial biopsies (EMBs) and clinical coronary vasculopathy (CAV) after orthotopic heart transplantation (OHT) remains controversial. Aim of the study was to find a potential relation between microvasculopathy features in late EMBs and clinically confirmed CAV in long-term OHT survivors.
Material/Methods: We performed a retrospective analysis involving 68 pts. in
whom OHT was performed before 1999 - CAV (+) group consisted of 37 pts.
(35M/2F, 45±11y/o, ischemic c-pathy in 57%) with established CAV (need for coronary angioplasty, myocardial infarction or CAV-related death), control group was composed of 31 pts. (24M/7F, 43±16y/o, ischemic c-pathy in 39%) with negative coronary angiography 10 years after OHT. Microvasculopathy was assessed in elective EMBs performed 12 and 36 months after OHT using the following features: presence of prominent endothelial cells, degeneration of the endothelium, thickening of the muscle layer, thickening of the basal membrane, presence of lymphocytes in the arteriolar wall without any other signs of rejection vasculitis, periarteriolar fibrosis, and an occluded arteriolar lumen. Rejection grades in analyzed EMBs were comparable in both groups.
Results: The only significant difference was observed in occurrence of thickening of the basal membrane which was present in 22% of pts. from CMV (+) group and 3% of individuals from the control group. All other features, both in 12 and 36 month EMB, were similarly distributed (including basal membrane thickening 36 months after OHT).
Conclusions: Microvasculopathy observed 12 and 36 months after OHT is not predictive for CAV development.

Keywords: Heart Transplantation

Add Comment 0 Comments

In Press

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

15 Mar 2024 : Review article  

Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...

Ann Transplant In Press; DOI: 10.12659/AOT.941185  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358